{"cluster": 36, "subcluster": 9, "abstract_summ": "Conclusions In the process of management of COVID-19 infections, close attention should be paid on both lung and cardiovascular damage, especially on those with only symptoms of cardiovascular diseases.The cardiovascular anti-inflammatory therapies might be of great application value to the management of COVID-19 patients and we further propose an algorithm for the selection of anti-inflammatory therapy for COVID-19 patients with or at high risk of cardiovascular impairment.Although the lungs are the main organs involved in acute respiratory distress syndrome caused by COVID-19 infection, COVID-19 triggers inflammatory and immune mechanisms, inducing a \u201ccytokine storm\u201d that aggravates disease progression and may lead to death.We believe that targeting the central pathway (IL-1\u03b2, TNF-\u03b1, IL-6), balancing the Th1 and Th2 response, and administering long-term anti-inflammatory therapy might be promising prospects to reduce cardiovascular impairment and even MODS during the acute and recovery phases of COVID-19.In addition, some of hospitalized COVID-19 patients had cardiovascular diseases in China.", "title_summ": "COVID-19: A tocsin to our aging, unfit, corpulent, and immunodeficient societyCardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory TherapyInfluence of COVID-19 on Cerebrovascular Disease and its Possible MechanismA close-up on COVID-19 and cardiovascular diseasesCould Autism Spectrum Disorders be a Risk Factor for COVID-19?Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19)The Science Underlying COVID-19: Implications for the Cardiovascular System.", "title_abstract_phrases": "A close-up on COVID-19 and cardiovascular diseasesAbstract Aims To analyze the potential mechanism of cardiovascular dysfunctions induced by Coronavirus Disease 2019 (COVID-19) and to evaluate more effective therapeutic pathways for patients with cardiovascular diseases.Conclusions In the process of management of COVID-19 infections, close attention should be paid on both lung and cardiovascular damage, especially on those with only symptoms of cardiovascular diseases.Therefore, to better understand the development of COVID-19 and the impacts of cardiovascular diseases will add valuable measures to the management of COVID-19 patients.We believe that targeting the central pathway (IL-1\u03b2, TNF-\u03b1, IL-6), balancing the Th1 and Th2 response, and administering long-term anti-inflammatory therapy might be promising prospects to reduce cardiovascular impairment and even MODS during the acute and recovery phases of COVID-19.Although the lungs are the main organs involved in acute respiratory distress syndrome caused by COVID-19 infection, COVID-19 triggers inflammatory and immune mechanisms, inducing a \u201ccytokine storm\u201d that aggravates disease progression and may lead to death."}